Trial intelligence / Profile preview

N-acetylcysteine for IVF outcomes in women with endometriosis-related infertility

IRCT20251226068442N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in endometriosis and female infertility comparing N-acetylcysteine with Placebo (2 arms). Primary endpoints: MII oocyte number, Implantation and 3 more. Started Feb 2026; status: completed.

02

Drugs

acetylcysteine
03

Conditions

endometriosisfemale infertility

Beyond the preview

Go deeper on IRCT20251226068442N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20251226068442N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call